dorfmanmaster

J&J vs opioids (Johnson is winning)

NYSE:JNJ   Johnson & Johnson
Fundamental analysis
In one of the first state opioid cases, an Oklahoma judge ruled against Johnson & Johnson, awarding the state $572 million, well below the over $17 billion the state was seeking in damages.
Meaning... out of the 17 billion, they lost only 3.36%, and they expect to appeal the case, probably lowering this amount.

Technical analysis
On a technical analysis, I still think the risk reward ratio is too small to enter a position now. But technicals are good (not great). So I am keeping this on my watchlist.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.